SCHEMBL4781028

SCHEMBL4781028

FC(F)(F)c1ccccc1N1CC2C(C1)C2N(Cc1ccccc1)Cc1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.43
ALDH1A1 P00352 1/20 0.43
ATM Q13315 1/20 0.43
HSD11B1 P28845 2/20 0.40
RBP4 P02753 2/20 0.38
KMT2A Q03164 1/20 0.37
TTR P02766 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
AKR1C3 P42330 1/20 0.35
ADRA1D P25100 1/20 0.34
ADRA1A P35348 1/20 0.34
ADRA1B P35368 1/20 0.34
NOTUM Q6P988 1/20 0.34
SIRT2 Q8IXJ6 1/20 0.34
SIRT1 Q96EB6 1/20 0.34
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
HTR2B P41595 1/20 0.33
MAPK14 Q16539 1/20 0.33
C5AR1 P21730 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4779453 0.90 NOTUM (0.46) KDM4EALDH1A1ATMHSD11B1RBP4
SCHEMBL4778369 0.82 NOTUM (0.40) KDM4EALDH1A1KMT2ANOTUM
SCHEMBL4776370 0.81 CHRM4 (0.42)
SCHEMBL4776176 0.79 FFAR4 (0.40) KMT2A
SCHEMBL4780332 0.78 CHRM4 (0.38) KDM4EALDH1A1KMT2ANOTUMCYP2C9
SCHEMBL4780839 0.78 SLC6A2 (0.44) NOTUM
SCHEMBL4780326 0.77 CHRM4 (0.40) KDM4EALDH1A1HTT
SCHEMBL4778958 0.76 ADRA1D (0.48) ALDH1A1ADRA1DADRA1AADRA1BCYP2C19
SCHEMBL4780977 0.76 ALOX15 (0.38) ADRA1A
SCHEMBL4779434 0.76 ADRA1D (0.48) ALDH1A1ADRA1DADRA1AADRA1BCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008010061-A2 3-AZABICYCLO [3.1.0] HEXANE VANILLOID RECEPTOR LIGANDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND PROCESSES FOR THEIR PREPARATION GLENMARK PHARMACEUTICALS S.A. (US) 2008-01-24 WO disclosed